Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021
Open Access
- 22 April 2021
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 26 (16), 2100413
- https://doi.org/10.2807/1560-7917.es.2021.26.16.2100413
Abstract
SARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1.7 and B.1.351, generally comparable to non-VOC strain.Keywords
This publication has 7 references indexed in Scilit:
- Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation studyThe Lancet Microbe, 2021
- Comparison of nine different commercially available molecular assays for detection of SARS-CoV-2 RNAEuropean Journal of Clinical Microbiology & Infectious Diseases, 2021
- The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In VitroJournal of Clinical Medicine, 2021
- Identification and molecular characterization of mutations in nucleocapsid phosphoprotein of SARS-CoV-2PeerJ, 2021
- Rethinking Covid-19 Test Sensitivity — A Strategy for ContainmentThe New England Journal of Medicine, 2020
- Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification (RT-LAMP)Virology Journal, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020